Unpacking Q1 Earnings: Axon (NASDAQ:AXON) In The Context Of Other Aerospace and Defense Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how aerospace and defense stocks fared in Q1, starting with Axon (NASDAQ:AXON). Emissions and automation are important in aerospace, so companies that boast advances in these areas can take market share. On the defense side, geopolitical tensions–whether it be Russia’s invasion of Ukraine or China’s aggression toward Taiwan–have highlighted the need for consistent or even elevated defense spending. As for challenges, demand for aerospace and defense products can ebb and flow with economic cycles and national defense budgets, which are unpredictable and particularly painful for companies with high fixed costs. The 29 aerospace and defense stocks we track reported a strong Q1; on average, revenues beat analyst consensus estimates by 3.9%. while next quarter's revenue guidance was 1.3% above consensus. Valuation multiples for many growth stocks have not yet reverted to their early 2021 highs, but the market was optimistic at the end of 2023 due to cooling inflation. The start of 2024 has been a different story as mixed signals have led to market volatility, but aerospace and defense stocks have shown resilience, with share prices up 8.1% on average since the previous earnings results. Axon (NASDAQ:AXON) Providing body cameras and tasers for first responders, AXON (NASDAQGS:AXON) develops technology solutions and weapons products for military, law enforcement, and civilians. Axon reported revenues of $460.7 million, up 34.3% year on year, exceeding analysts' expectations by 4.3%. Overall, it was an incredible quarter for the company with an impressive beat of analysts' volume and earnings estimates. Axon Total Revenue The stock is down 10.6% since reporting and currently trades at $293.32. We think Axon is a good business, but is it a buy today? Read our full report here, it's free. Best Q1: Moog (NYSE:MOG.A) Responsible for the flight control actuation system integrated in the B-2 stealth bomber, Moog (NYSE:MOG.A) provides precision motion control solutions used in aerospace and defense applications. Moog reported revenues of $930.3 million, up 11.2% year on year, outperforming analysts' expectations by 6.5%. It was an incredible quarter for the company, with an impressive beat of analysts' revenue estimates. Moog Total Revenue The market seems happy with the results as the stock is up 16.2% since reporting. It currently trades at $182.84. Is now the time to buy Moog? Access our full analysis of the earnings results here, it's free. Weakest Q1: Mercury Systems (NASDAQ:MRCY) Founded in 1981, Mercury Systems (NASDAQ:MRCY) specializes in providing processing subsystems and components for primarily defense applications. Mercury Systems reported revenues of $208.3 million, down 21% year on year, falling short of analysts' expectations by 2.9%. It was a weak quarter for the company with a miss of analysts' earnings and organic revenue estimates. Mercury Systems posted the slowest revenue growth in the group. Interestingly, the stock is up 7.1% since the results and currently trades at $31.18. Read our full analysis of Mercury Systems's results here. Cadre (NYSE:CDRE) Originally known as Safariland, Cadre (NYSE:CDRE) specializes in the manufacturing and distribution of safety and survivability equipment for first responders. Cadre reported revenues of $137.9 million, up 23.4% year on year, surpassing analysts' expectations by 7.7%. Zooming out, it was a very strong quarter for the company with an impressive beat of analysts' Products revenue estimates. The stock is up 7.1% since reporting and currently trades at $36.81. Read our full, actionable report on Cadre here, it's free. Woodward (NASDAQ:WWD) Initially designing controls for water wheels in the early 1900s, Woodward (NASDAQ:WWD) designs, services, and manufactures energy control products and optimization solutions. Woodward reported revenues of $835.3 million, up 16.3% year on year, surpassing analysts' expectations by 3.3%. Revenue aside, it was a stunning quarter for the company with an impressive beat of analysts' organic revenue estimates and optimistic earnings guidance for the full year. The stock is up 17.1% since reporting and currently trades at $176.70. Read our full, actionable report on Woodward here, it's free. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
Unpacking Q1 Earnings: Axon (NASDAQ:AXON) In The Context Of Other Aerospace and Defense Stocks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...